We are live on ! Find out more
EMFAT

Emerald Mutual Fund Advisers Trust Portfolio holdings

AUM $2.06B
1-Year Est. Return 106.87%
This Fund
S&P 500
This Quarter Est. Return
+16.75%
1 Year Est. Return
+106.87%
3 Year Est. Return
+347.49%
5 Year Est. Return
+440.43%
10 Year Est. Return
+3,482.63%
AUM
$2.45B
AUM Growth
+$190M
Cap. Flow
-$50.3M
Cap. Flow %
-2.05%
Top 10 Hldgs %
18.35%
Holding
310
New
106
Increased
57
Reduced
61
Closed
23

Top Buys

Rank Stock Value
1
BRBR icon
BellRing Brands
BRBR
+$30.8M
2
QTS
QTS REALTY TRUST, INC.
QTS
+$18.2M
3
BWIN
Baldwin Insurance Group
BWIN
+$14.6M
4
PRFT
Perficient Inc
PRFT
+$14.6M
5
AX icon
Axos Financial
AX
+$14.4M

Top Sells

Rank Stock Value
1
RETA
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
+$30.9M
2
CADE
Cadence Bancorporation
CADE
+$29.1M
3
VG
Vonage Holdings Corporation
VG
+$15.7M
4
KPTI icon
Karyopharm Therapeutics
KPTI
+$13.7M
5
ARNA
Arena Pharmaceuticals Inc
ARNA
+$12.9M

Sector Composition

Rank Sector Weight
1 Healthcare 20.08%
2 Financials 17.24%
3 Consumer Discretionary 15.54%
4 Industrials 14.09%
5 Technology 12.48%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BHVN
26
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
$25M 1.02%
458,609
+154,005
+51% +$7.63M
JACK icon
27
Jack in the Box
JACK
$331M
$24.5M 1%
313,993
– –
YETI icon
28
Yeti Holdings
YETI
$3.8B
$24.4M 1%
700,948
+101,640
+17% +$3.2M
MRTX
29
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
$24.3M 0.99%
188,651
+60,580
+47% +$5.84M
VIAV icon
30
Viavi Solutions
VIAV
$9.28B
$24M 0.98%
1,602,496
+772,180
+93% +$11.6M
EVRI
31
DELISTED
Everi Holdings
EVRI
$23.5M 0.96%
1,749,201
+294,761
+20% +$3.36M
MODN
32
DELISTED
MODEL N, INC.
MODN
$22.9M 0.93%
651,669
– –
NVRI icon
33
Enviri
NVRI
$637M
$22.8M 0.93%
991,052
+494,694
+100% +$10.3M
CCOI icon
34
Cogent Communications
CCOI
$683M
$22.6M 0.92%
343,715
+29,540
+9% +$1.78M
PRFT
35
DELISTED
Perficient Inc
PRFT
$22.6M 0.92%
490,018
+358,145
+272% +$14.6M
MTH icon
36
Meritage Homes
MTH
$4.67B
$21.7M 0.89%
710,284
– –
PS
37
DELISTED
Pluralsight, Inc. Class A Common Stock
PS
$21.4M 0.88%
1,245,108
+3,118
+0.3% +$53.1K
FSCT
38
DELISTED
ForeScout Technologies, Inc. Common Stock
FSCT
$21M 0.86%
639,551
-284,180
-31% -$9.32M
NSP icon
39
Insperity
NSP
$2.04B
$20.7M 0.84%
240,107
+31,190
+15% +$2.71M
TNDM icon
40
Tandem Diabetes Care
TNDM
$1.38B
$20.4M 0.83%
342,858
-199,472
-37% -$12.3M
ADUS icon
41
Addus HomeCare
ADUS
$2.16B
$20.1M 0.82%
206,455
– –
RETA
42
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
$20M 0.82%
97,804
-169,517
-63% -$30.9M
AIMT
43
DELISTED
Aimmune Therapeutics
AIMT
$19.7M 0.8%
587,464
– –
OCFC icon
44
OceanFirst Financial
OCFC
$1.69B
$19.3M 0.79%
756,394
+46,805
+7% +$1.13M
QTS
45
DELISTED
QTS REALTY TRUST, INC.
QTS
$18.8M 0.77%
+346,418
New +$18.2M
AEO icon
46
American Eagle Outfitters
AEO
$2.92B
$18.4M 0.75%
1,250,937
– –
PTCT icon
47
PTC Therapeutics
PTCT
$5.71B
$18M 0.74%
374,846
+11,434
+3% +$486K
SAIL
48
DELISTED
SailPoint Technologies Holdings, Inc. Common Stock
SAIL
$17.8M 0.73%
753,932
+228,938
+44% +$5.01M
APLT
49
DELISTED
Applied Therapeutics
APLT
$17.3M 0.71%
632,750
+100,488
+19% +$1.72M
AJRD
50
DELISTED
Aerojet Rocketdyne Holdings
AJRD
$17.2M 0.7%
377,775
+57,210
+18% +$2.59M
1
2
3 4 5

Similar funds

BMCM
Bryn Mawr Capital Management Philadelphia, Pennsylvania $2.06B AUM 19.82% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
WFMPM
Woodley Farra Manion Portfolio Management Indianapolis, Indiana $2.05B AUM 14.54% 1-Year Est. Return
HBT
Hills Bank & Trust North Liberty, Iowa $2.07B AUM 13.46% 1-Year Est. Return
BC
BIT Capital Berlin, Germany $2.07B AUM 157.17% 1-Year Est. Return
SW
SoFi Wealth San Francisco, California $2.08B AUM 18.22% 1-Year Est. Return
RC
RBF Capital San Francisco, California $2.05B AUM 29.64% 1-Year Est. Return
AG
Avala Global New York $2.08B AUM 87.66% 1-Year Est. Return

Emerald Mutual Fund Advisers Trust's Q4 2019 Portfolio in Review

As of Q4 2019, Emerald Mutual Fund Advisers Trust held 310 positions worth $2.45B, up 8.4% from $2.26B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Emerald Mutual Fund Advisers Trust's Q4 2019 filing shows 106 new, 57 increased, 61 reduced and 23 closed positions. Its largest new stake was BellRing Brands: 1,572,144 shares worth $33.5M. The largest sale was Reata Pharmaceuticals, Inc. Class A Common Stock, an estimated $30.9M.

By sector, the portfolio is most concentrated in Healthcare at 20% of assets, up from 20% a quarter earlier, followed by Financials and Consumer Discretionary.

  • Emerald Mutual Fund Advisers Trust's largest Q4 2019 buy was BellRing Brands: 1,572,144 shares worth $33.5M.
  • Emerald Mutual Fund Advisers Trust added most to Perficient Inc in Q4 2019, an estimated $14.6M increase.
  • Emerald Mutual Fund Advisers Trust's biggest Q4 2019 reduction was Reata Pharmaceuticals, Inc. Class A Common Stock, cutting an estimated $30.9M.
  • Emerald Mutual Fund Advisers Trust fully exited Arena Pharmaceuticals Inc in Q4 2019, selling an estimated $12.9M.
  • Emerald Mutual Fund Advisers Trust's ten largest holdings make up 18% of its $2.45B portfolio in Q4 2019.
  • Emerald Mutual Fund Advisers Trust opened 106 new positions and closed 23 in Q4 2019.
  • Emerald Mutual Fund Advisers Trust's portfolio value rose 8.4% quarter-over-quarter to $2.45B.

Based on Emerald Mutual Fund Advisers Trust's 13F filing for Q4 2019, filed 29 Jan 2020.